Portolan Capital Management, LLC Trans Medics Group, Inc. Transaction History
Portolan Capital Management, LLC
- $1.6 Billion
- Q3 2025
A detailed history of Portolan Capital Management, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 68,910 shares of TMDX stock, worth $7.93 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
68,910Holding current value
$7.93 Million% of portfolio
0.48%Shares
6 transactions
Others Institutions Holding TMDX
# of Institutions
438Shares Held
30.4MCall Options Held
1.01MPut Options Held
928K-
Vanguard Group Inc Valley Forge, PA3.61MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$304 Million0.01% of portfolio
-
State Street Corp Boston, MA1.28MShares$147 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.07MShares$123 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$104 Million0.12% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.66B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...